Medical Acoustics, a medical device company which employs acoustic technologies for diagnostic and therapeutic medical applications, has been awarded a UB CAT/NYSTAR grant for Lung Flute clinical trial.
The Lung Flute is a non-invasive medical device that uses patented low-frequency acoustic wave technology to stimulate the body’s natural mucus-clearing system.
The device has been cleared by the US Food and Drug Administration for therapeutic and diagnostic use in individuals with chronic obstructive pulmonary disease (COPD) and other respiratory diseases.
The $75,000 grant, awarded by the University at Buffalo Center for Advanced Biomedical and Bioengineering Technology (UB CAT) and funded by the New York State Foundation for Science Technology and Innovation, will help to finance a clinical trial entitled, ‘Six Month Clinical Trial of Lung Flute in Patients with COPD’.
The total cost of the study is expected to be approximately $250,000.
The trial’s primary outcome measure is to evaluate the change in chronic obstructive pulmonary disease (COPD) symptoms assessed by the Clinical COPD Questionnaire (CCQ) between the intervention and control group.
Medical Acoustics Science and Technology vice president Nicolaas Smit said that this extensive clinical study will further demonstrate the health benefits of using the Lung Flute as part of daily Bronchial Hygiene Therapy.